Foresite Capital Management IV as of Dec. 31, 2021
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 9 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 35.3 | $171M | 9.7M | 17.72 | |
| Lyell Immunopharma (LYEL) | 21.2 | $103M | 13M | 7.74 | |
| Aclaris Therapeutics (ACRS) | 10.2 | $49M | 3.4M | 14.54 | |
| Pharvaris N V (PHVS) | 9.7 | $47M | 3.3M | 14.39 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 7.2 | $35M | 4.5M | 7.87 | |
| Nurix Therapeutics (NRIX) | 7.2 | $35M | 1.2M | 28.95 | |
| Kura Oncology (KURA) | 5.3 | $26M | 1.8M | 14.00 | |
| Cue Health (HLTHQ) | 2.8 | $14M | 1.0M | 13.41 | |
| Cymabay Therapeutics | 1.2 | $6.0M | 1.8M | 3.38 |
